Hudson Bay Capital Management
VERA icon

Hudson Bay Capital Management’s Vera Therapeutics VERA Stock Holding History

Hudson Bay Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-192,439
Closed -$7.74M – 1713
2026
Q1 		$7.74M Buy
+192,439
New +$8.29M 0.03% 371
2025
Q4 		– Sell
-440,591
Closed -$12.8M – 1544
2025
Q3 		$12.8M Buy
440,591
+141,615
+47% +$3.27M 0.04% 308
2025
Q2 		$7.04M Buy
+298,976
New +$6.72M 0.02% 453
2024
Q4 		– Sell
-30,500
Closed -$1.35M – 1124
2024
Q3 		$1.35M Sell
30,500
-13,800
-31% -$524K 0.01% 618
2024
Q2 		$1.6M Buy
44,300
+4,300
+11% +$171K 0.01% 550
2024
Q1 		$1.72M Buy
+40,000
New +$1.43M 0.01% 478

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hudson Bay Capital Management's VERA Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 192,439 shares — an estimated $7.74M sold.

Hudson Bay Capital Management first reported a position in VERA in Q1 2024 and held it in 6 quarters. The position peaked at $12.8M in Q3 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 192,439 Vera Therapeutics shares in Q2 2026, an estimated $7.74M.
  • Hudson Bay Capital Management first reported a position in Vera Therapeutics in Q1 2024 and held it in 6 quarters.
  • Hudson Bay Capital Management's Vera Therapeutics position peaked at $12.8M in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.